Predictions
Curevac N.V.
Start price
Target price
Perf. (%)
€48.93
17.06.21
17.06.21
€55.00
17.06.22
17.06.22
3.59%
25.06.21
25.06.21
Could be worthwhile Investment >10% per year
Innovative
Future proof or reliable business model
Higher risks for its business
Curevac N.V.
Start price
Target price
Perf. (%)
€49.88
21.06.21
21.06.21
-
17.06.22
17.06.22
2.00%
22.06.21
22.06.21
Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Curevac N.V.
Start price
Target price
Perf. (%)
€48.56
17.06.21
17.06.21
-
17.06.22
17.06.22
2.73%
21.06.21
21.06.21
Could be worthwhile Investment >10% per year
Fair valuation
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Curevac N.V.
Start price
Target price
Perf. (%)
€52.00
05.09.20
05.09.20
-
04.11.21
04.11.21
80.96%
03.06.21
03.06.21
Could be very worthwhile Investment >20% year
Curevac N.V.
Start price
Target price
Perf. (%)
€105.96
08.02.21
08.02.21
-
08.02.22
08.02.22
2.02%
28.04.21
28.04.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Curevac N.V.
Start price
Target price
Perf. (%)
€52.00
06.09.20
06.09.20
-
04.11.21
04.11.21
79.81%
18.04.21
18.04.21
Could be very worthwhile Investment >20% year
Curevac N.V.
Start price
Target price
Perf. (%)
€70.04
05.03.21
05.03.21
-
15.48%
20.03.21
20.03.21
Could be worthwhile Investment >10% per year
Curevac N.V.
Start price
Target price
Perf. (%)
€97.47
09.02.21
09.02.21
€100.00
-24.24%
13.03.21
13.03.21
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Curevac N.V.
Start price
Target price
Perf. (%)
€81.89
13.01.21
13.01.21
€101.00
23.31%
08.02.21
08.02.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Curevac N.V.
Start price
Target price
Perf. (%)
€72.27
28.11.20
28.11.20
-
28.11.21
28.11.21
51.90%
10.12.20
10.12.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation